Today Biogen has submitted an application with the FDA for marketing permission of oral BG-12. they will file for permission in the EU within the next few days...Right on target.
http://www.nasdaq.com/article/biogen...20120228-00631
http://www.finanzen.net/nachricht/Bi...erosis-1690352
http://www.nasdaq.com/article/biogen...20120228-00631
http://www.finanzen.net/nachricht/Bi...erosis-1690352
Comment